125 related articles for article (PubMed ID: 31900071)
21. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of
Zhang J; Liu Q; Singh A; Schuchardt C; Kulkarni HR; Baum RP
J Nucl Med; 2020 Nov; 61(11):1560-1569. PubMed ID: 32169914
[TBL] [Abstract][Full Text] [Related]
23. Calcitonin-secreting tumor of the pancreas.
Mullerpatan PM; Joshi SR; Shah RC; Tampi CS; Doctor VM; Jagannath P; Modlin I
Dig Surg; 2004; 21(4):321-4. PubMed ID: 15375334
[TBL] [Abstract][Full Text] [Related]
24. Calcitonin-secreting tumors of the pancreas: about six cases.
Fleury A; Fléjou JF; Sauvanet A; Molas G; Vissuzaine C; Hammel P; Lévy P; Belghiti J; Bernades P; Ruszniewski P
Pancreas; 1998 May; 16(4):545-50. PubMed ID: 9598818
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.
Kowalski J; Henze M; Schuhmacher J; Mäcke HR; Hofmann M; Haberkorn U
Mol Imaging Biol; 2003; 5(1):42-8. PubMed ID: 14499161
[TBL] [Abstract][Full Text] [Related]
26. [Contemporary nuclear medicine diagnostics of neuroendocrine tumors].
Srp Arh Celok Lek; 2015; 143(1-2):108-15. PubMed ID: 25845263
[TBL] [Abstract][Full Text] [Related]
27. The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors.
Frilling A; Sotiropoulos GC; Radtke A; Malago M; Bockisch A; Kuehl H; Li J; Broelsch CE
Ann Surg; 2010 Nov; 252(5):850-6. PubMed ID: 21037441
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity Comparison of
Nicolas GP; Schreiter N; Kaul F; Uiters J; Bouterfa H; Kaufmann J; Erlanger TE; Cathomas R; Christ E; Fani M; Wild D
J Nucl Med; 2018 Jun; 59(6):915-921. PubMed ID: 29191855
[TBL] [Abstract][Full Text] [Related]
29. A primary neuroendocrine tumor of the left ventricle presenting with diarrhea-an unusual experience and literature review.
Li C; Huang J; Yang X; Xia J; Xu G; Zheng H
Diagn Pathol; 2020 Apr; 15(1):32. PubMed ID: 32245475
[TBL] [Abstract][Full Text] [Related]
30. Molecular imaging of late somatostatin receptor-positive metastases of renal cell carcinoma in the pancreas by 68Ga DOTATOC PET/CT: a rare differential diagnosis to multiple primary pancreatic neuroendocrine tumors.
Peter L; Sänger J; Hommann M; Baum RP; Kaemmerer D
Clin Nucl Med; 2014 Aug; 39(8):713-6. PubMed ID: 24561680
[TBL] [Abstract][Full Text] [Related]
31. Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours?
Al-Ibraheem A; Bundschuh RA; Notni J; Buck A; Winter A; Wester HJ; Schwaiger M; Scheidhauer K
Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):2005-13. PubMed ID: 21792572
[TBL] [Abstract][Full Text] [Related]
32. Detection of pancreatic neuroendocrine tumors (PNET) using semi-quantitative [68Ga]DOTATOC PET in combination with multiphase contrast-enhanced CT.
Froeling V; Röttgen R; Collettini F; Rothe J; Hamm B; Brenner W; Schreiter N
Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):310-8. PubMed ID: 25265251
[TBL] [Abstract][Full Text] [Related]
33. Problems of diagnostic assessment in advanced pancreatic neuroendocrine neoplasm and treatment implications: a case report and literature review.
Szymanowski B; Duchnowska R; Bilski M; Łapińska G; Hryciuk B; Kamiński G; Szczylik C
Nucl Med Rev Cent East Eur; 2016; 19(1):54-7. PubMed ID: 26838946
[TBL] [Abstract][Full Text] [Related]
34. Recurrent Metastatic Medullary Thyroid Carcinoma: A Case of Sustained Response to Prolonged Treatment with Somatostatin Analogues.
Cano JM; Galán R; López R
Thyroid; 2017 Nov; 27(11):1450-1455. PubMed ID: 28927353
[TBL] [Abstract][Full Text] [Related]
35. The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.
Hindié E
Theranostics; 2017; 7(5):1159-1163. PubMed ID: 28435455
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic Neuroendocrine Tumor presenting as a diffuse pancreatic enlargement, case report and review of literature.
Salahshour F; Taslimi R; Moosavi NS; Yazdi NA; Esfandbod M
J Radiol Case Rep; 2021 Jan; 15(1):11-20. PubMed ID: 33717403
[TBL] [Abstract][Full Text] [Related]
37. Chronic Diarrhea Secondary to Newly Diagnosed VIPoma.
Farina DA; Krogh KM; Boike JR
Case Rep Gastroenterol; 2019; 13(1):225-229. PubMed ID: 31123451
[TBL] [Abstract][Full Text] [Related]
38. Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor.
Stoeltzing O; Loss M; Huber E; Gross V; Eilles C; Mueller-Brand J; Schlitt HJ
Langenbecks Arch Surg; 2010 Feb; 395(2):185-92. PubMed ID: 19506898
[TBL] [Abstract][Full Text] [Related]
39. Radio-guided surgery and postoperative PET/CT scan of a surgical specimen of an intraosseous meningioma in a patient with neuroendocrine tumor of the pancreas.
Meiser M; Winkens T; Freesmeyer M
Clin Nucl Med; 2015 May; 40(5):419-20. PubMed ID: 25742227
[TBL] [Abstract][Full Text] [Related]
40. Role of (68)Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours.
Kumar R; Sharma P; Garg P; Karunanithi S; Naswa N; Sharma R; Thulkar S; Lata S; Malhotra A
Eur Radiol; 2011 Nov; 21(11):2408-16. PubMed ID: 21750886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
